Camber Capital Management’s Novavax NVAX Stock Holding History

Camber Capital Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-100,000	Closed	-$11.9M	–	41
2014 Q4	$11.9M	Sell	100,000 -137,500	-58%	-$14.4M	0.79%	32
2014 Q3	$19.8M	Hold	237,500	–	–	1.86%	21
2014 Q2	$21.9M	Buy	237,500 +125,000	+111%	+$11M	1.44%	23
2014 Q1	$10.2M	Sell	112,500 -62,500	-36%	-$6.98M	0.8%	29
2013 Q4	$17.9M	Sell	175,000 -60,550	-26%	-$4.28M	1.58%	21
2013 Q3	$14.9M	Buy	235,550 +75,000	+47%	+$4.22M	1.56%	21
2013 Q2	$6.58M	Buy	+160,550	New	+$6.96M	0.68%	37

Other funds holding NVAX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Camber Capital Management's NVAX Position: Q1 2015 in Review

Camber Capital Management sold out of Novavax (NVAX) in Q1 2015, closing a stake of 100,000 shares — an estimated $11.9M sold.

Camber Capital Management first reported a position in NVAX in Q2 2013 and held it in 7 quarters. The position peaked at $21.9M in Q2 2014. 167 funds tracked by Wall St. Rank hold NVAX as of Q1 2015.

Camber Capital Management reported no remaining Novavax position as of Q1 2015 after selling out during the quarter.
Camber Capital Management sold 100,000 Novavax shares in Q1 2015, an estimated $11.9M.
Camber Capital Management first reported a position in Novavax in Q2 2013 and held it in 7 quarters.
Camber Capital Management's Novavax position peaked at $21.9M in Q2 2014.
167 funds tracked by Wall St. Rank held Novavax as of Q1 2015.

Based on Camber Capital Management's 13F filing for Q1 2015, filed 15 May 2015.